相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A new scoring system for the grading of conventional chondrosarcoma: Its clinicopathological significance
Yosuke Susuki et al.
PATHOLOGY RESEARCH AND PRACTICE (2022)
NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study
Madiha Syed et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2021)
In-Depth Characterization of Stromal Cells within the Tumor Microenvironment Yields Novel Therapeutic Targets
Sebastian G. Walter et al.
CANCERS (2021)
Immunotherapy for Chordoma and Chondrosarcoma: Current Evidence
Jeffrey I. Traylor et al.
CANCERS (2021)
Risk analysis of pulmonary metastasis of chondrosarcoma by establishing and validating a new clinical prediction model: a clinical study based on SEER database
Wenle Li et al.
BMC MUSCULOSKELETAL DISORDERS (2021)
Dedifferentiated Central Chondrosarcoma: A Clinical, Histopathological, and Immunohistochemical Analysis of 57 Cases
Li-Hua Gong et al.
FRONTIERS IN MEDICINE (2021)
Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma
Warren Chow et al.
CANCER (2020)
Survival and Prognosis of Chondrosarcoma Subtypes: SEER Database Analysis
Kamil M. Amer et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2020)
Lactate in Sarcoma Microenvironment: Much More than just a Waste Product
Maria Letizia Taddei et al.
CELLS (2020)
The immune landscape of chondrosarcoma - potential for therapeutic targeting of CSFR1+macrophages
Iseulys Richert et al.
JOURNAL OF BONE ONCOLOGY (2020)
Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma
William D. Tap et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
A system-level approach identifies HIF-2α as a critical regulator of chondrosarcoma progression
Hyeonkyeong Kim et al.
NATURE COMMUNICATIONS (2020)
Crosstalk Between Mesenchymal Stromal Cells and Tumor-Associated Macrophages in Gastric Cancer
Ping Zheng et al.
FRONTIERS IN ONCOLOGY (2020)
Therapeutic effect of palbociclib in chondrosarcoma: implication of cyclin-dependent kinase 4 as a potential target
Zhengxiao Ouyang et al.
CELL COMMUNICATION AND SIGNALING (2019)
Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma
Choh Yeung et al.
CANCER RESEARCH (2019)
Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma
Makoto Nakagawa et al.
ONCOGENE (2019)
Integrated molecular characterization of chondrosarcoma reveals critical determinants of disease progression
Remy Nicolle et al.
NATURE COMMUNICATIONS (2019)
Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study
Florence Duffaud et al.
LANCET ONCOLOGY (2019)
Immune checkpoint inhibitors in sarcomas: in quest of predictive biomarkers
Robin Veenstra et al.
LABORATORY INVESTIGATION (2018)
Biomarkers of chondrosarcoma
Wonju Jeong et al.
JOURNAL OF CLINICAL PATHOLOGY (2018)
Chondrosarcoma: An overview of clinical behavior, molecular mechanisms mediated drug resistance and potential therapeutic targets
Elahe Nazeri et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Molecular biology of sarcoma
Michal Fiedorowicz et al.
ONCOLOGY IN CLINICAL PRACTICE (2018)
Biology of Bone Sarcomas and New Therapeutic Developments
Hannah K. Brown et al.
CALCIFIED TISSUE INTERNATIONAL (2018)
Phase 2 Study of Dasatinib in Patients With Alveolar Soft Part Sarcoma, Chondrosarcoma, Chordoma, Epithelioid Sarcoma, or Solitary Fibrous Tumor
Scott M. Schuetze et al.
CANCER (2017)
Description of the immune microenvironment of chondrosarcoma and contribution to progression
Francois A. Simard et al.
ONCOIMMUNOLOGY (2017)
Cancer-associated mesenchymal stroma fosters the stemness of osteosarcoma cells in response to intratumoral acidosis via NF-κB activation
Sofia Avnet et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hussein A. Tawbi et al.
LANCET ONCOLOGY (2017)
Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcoma
Robin L. Jones et al.
MEDICAL ONCOLOGY (2017)
Doxycycline and its quaternary ammonium derivative for adjuvant therapies of chondrosarcoma
Imen Miladi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
THE EFFECT OF EXTRACELLULAR ACIDOSIS ON THE BEHAVIOUR OF MESENCHYMAL STEM CELLS IN VITRO
A. Massa et al.
EUROPEAN CELLS & MATERIALS (2017)
Recurrence rate and progression of chondrosarcoma is correlated with heat shock protein expression
Klemens Trieb et al.
ONCOLOGY LETTERS (2016)
Analysis of PD-L1, T-cell infiltrate and HLA expression in chondrosarcoma indicates potential for response to immunotherapy specifically in the dedifferentiated subtype
Marie Kostine et al.
MODERN PATHOLOGY (2016)
miR-125b acts as a tumor suppressor in chondrosarcoma cells by the sensitization to doxorubicin through direct targeting the ErbB2-regulated glucose metabolism
Kai-jin Guo et al.
Drug Design Development and Therapy (2016)
Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
L. Paoluzzi et al.
CLINICAL SARCOMA RESEARCH (2016)
Bone cancer incidence by morphological subtype: a global assessment
Patricia C. Valery et al.
CANCER CAUSES & CONTROL (2015)
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
Nabil Ahmed et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The transcription factors SOX9 and SOX5/SOX6 cooperate genome-wide through super-enhancers to drive chondrogenesis
Chia-Feng Liu et al.
NUCLEIC ACIDS RESEARCH (2015)
Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells
Luyuan Li et al.
PLOS ONE (2015)
Identification of novel biomarker candidates for immunohistochemical diagnosis to distinguish low-grade chondrosarcoma from enchondroma
Xianyin Lai et al.
PROTEOMICS (2015)
MicroRNA-100 Resensitizes Resistant Chondrosarcoma Cells to Cisplatin through Direct Targeting of mTOR
Zhe Zhu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Small rigid platforms functionalization with quaternary ammonium: Targeting extracellular matrix of chondrosarcoma
Elisabeth Miot-Noirault et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcoma
Ioannis Panagopoulos et al.
ONCOLOGY REPORTS (2014)
Hedgehog pathway inhibitor-4 suppresses malignant properties of chondrosarcoma cells by disturbing tumor ciliogenesis
Wei Xiang et al.
ONCOLOGY REPORTS (2014)
Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells
Gloria Bonuccelli et al.
ONCOTARGET (2014)
Swarm chondrosarcoma: a continued resource for chondroblastic-like extracellular matrix and chondrosarcoma biology research
Jeff W. Stevens
CONNECTIVE TISSUE RESEARCH (2013)
Loss of RUNX3 expression may contribute to poor prognosis in patients with chondrosarcoma
Zhe Jin et al.
JOURNAL OF MOLECULAR HISTOLOGY (2013)
Dentine matrix protein 1 (DMP-1) is a marker of bone-forming tumours
T. G. Kashima et al.
VIRCHOWS ARCHIV (2013)
Clinical activity of mTOR inhibition in combination with cyclophosphamide in the treatment of recurrent unresectable chondrosarcomas
Rinat Bernstein-Molho et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Expression of Aurora Kinase A and B in chondrosarcoma and its relationship with the prognosis
Xiaohui Liang et al.
DIAGNOSTIC PATHOLOGY (2012)
Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data
Lu Wang et al.
GENES CHROMOSOMES & CANCER (2012)
Genetic characterization of mesenchymal, clear cell, and dedifferentiated chondrosarcoma
Danielle Meijer et al.
GENES CHROMOSOMES & CANCER (2012)
Incidence and survival of malignant bone sarcomas in England 1979-2007
Jeremy Whelan et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Inhibition of Chondrosarcoma Growth by mTOR Inhibitor in an In Vivo Syngeneic Rat Model
Jennifer Perez et al.
PLOS ONE (2012)
Association of Elevated HIF-2α Levels with Low Beclin 1 Expression and Poor Prognosis in Patients with Chondrosarcoma
Changbao Chen et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
A Phase 2 Trial of Imatinib Mesylate in Patients With Recurrent Nonresectable Chondrosarcomas Expressing Platelet-Derived Growth Factor Receptor-α or -β An Italian Sarcoma Group Study
Giovanni Grignani et al.
CANCER (2011)
IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
M. Fernanda Amary et al.
JOURNAL OF PATHOLOGY (2011)
Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome
Twinkal C. Pansuriya et al.
NATURE GENETICS (2011)
FLI-1 Distinguishes Ewing Sarcoma From Small Cell Osteosarcoma and Mesenchymal Chondrosarcoma
Anna F. Lee et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2011)
Immunoprofile of mesenchymal chondrosarcoma: aberrant desmin and EMA expression retention of INI1, and negative estrogen receptor in 22 female-predominant central nervous system and musculoskeletal cases
Julie C. Fanburg-Smith et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2010)
Microenvironment alters epigenetic and gene expression profiles in Swarm rat chondrosarcoma tumors
Christopher A. Hamm et al.
BMC CANCER (2010)
The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
Patrick S. Ward et al.
CANCER CELL (2010)
Different expression of Sox9 and Runx2 between chondrosarcoma and dedifferentiated chondrosarcoma cell line
Xiaodong Tang et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2010)
Immunohistochemical analysis for Sox9 reveals the cartilaginous character of chondroblastoma and chondromyxoid fibroma of the bone
Eiichi Konishi et al.
HUMAN PATHOLOGY (2010)
Galectin-1 is a powerful marker to distinguish chondroblastic osteosarcoma and conventional chondrosarcoma
Anne Gomez-Brouchet et al.
HUMAN PATHOLOGY (2010)
Sox9 Expression Is Not Limited to Chondroid Neoplasms: Variable Occurrence in Other Soft Tissue and Bone Tumors With Frequent Expression by Synovial Sarcomas
Mariana M. Cajaiba et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2010)
Cartilage tumours and bone development: molecular pathology and possible therapeutic targets
Judith V. M. G. Bovee et al.
NATURE REVIEWS CANCER (2010)
Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model
Bo Sun et al.
CYTOTHERAPY (2009)
Chondrosarcoma in the United States (1973 to 2003): An Analysis of 2890 Cases from the SEER Database
Angela Ylenia Giuffrida et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2009)
The Heparan Sulfate Proteoglycan (HSPG) Glypican-3 Mediates Commitment of MC3T3-E1 Cells Toward Osteogenesis
Larisa M. Haupt et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
Elaine R. Mardis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Osteosarcoma, chondrosarcoma, and Ewing's sarcoma
Timothy A. Damron et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2007)
Constitutive hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation
TD Tiet et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
MYC amplification and polysomy 8 in chondrosarcoma: Array comparative genomic hybridization, fluorescent in situ hybridization, and association with outcome
C Morrison et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Imaging of primary chondrosarcoma: Radiologic-pathologic correlation
MD Murphey et al.
RADIOGRAPHICS (2003)
Transforming growth factor-β isoform and receptor expression in chondrosarcoma of bone
L Masi et al.
VIRCHOWS ARCHIV (2002)
Human chondrosarcoma secretes vascular endothelial growth factor to induce tumor angiogenesis and stores basic fibroblast growth factor for regulation of its own growth
T Furumatsu et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
分享论文
